{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:20:40Z","timestamp":1785853240376,"version":"3.56.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T00:00:00Z","timestamp":1711756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T00:00:00Z","timestamp":1711756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-03791-7","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T18:01:46Z","timestamp":1711821706000},"page":"873-882","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Long-term effectiveness of zoledronic acid in patients with Paget\u2019s disease of bone \u2013 a retrospective cohort study"],"prefix":"10.1007","volume":"85","author":[{"given":"Irit","family":"Ayalon-Dangur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaron","family":"Rudman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Tsvetov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Slutzky-Shraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Akirov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Shimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Gorshtein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,30]]},"reference":[{"issue":"5","key":"3791_CR1","doi-asserted-by":"publisher","first-page":"11S","DOI":"10.1016\/S8756-3282(99)00027-7","volume":"24","author":"M Davie","year":"1999","unstructured":"M. Davie, M. Davies, R. Francis, W. Fraser, D. Hosking, R. Tansley, Paget\u2019s disease of bone: a review of 889 patients. Bone 24(5), 11S\u201312S (1999). https:\/\/doi.org\/10.1016\/S8756-3282(99)00027-7","journal-title":"Bone"},{"issue":"3","key":"3791_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1359\/jbmr.2000.15.3.461","volume":"15","author":"RD Altman","year":"2010","unstructured":"R.D. Altman, D.A. Bloch, M.C. Hochberg, W.A. Murphy, Prevalence of pelvic Paget\u2019s disease of bone in the United States. J. Bone Min. Res 15(3), 461\u2013465 (2010). https:\/\/doi.org\/10.1359\/jbmr.2000.15.3.461","journal-title":"J. Bone Min. Res"},{"issue":"2","key":"3791_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1359\/jbmr.1999.14.2.192","volume":"14","author":"C Cooper","year":"1999","unstructured":"C. Cooper, K. Schafheutle, E. Dennison, S. Kellingray, P. Guyer, D. Barker, The epidemiology of Paget\u2019s disease in Britain: is the prevalence decreasing? J. Bone Min. Res 14(2), 192\u2013197 (1999). https:\/\/doi.org\/10.1359\/jbmr.1999.14.2.192","journal-title":"J. Bone Min. Res"},{"key":"3791_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2023.116721","volume":"170","author":"E Gendron","year":"2023","unstructured":"E. Gendron, F. Bouchard, N. Singbo, J.P. Brown, L. Michou, Decline in clinical severity of Paget\u2019s disease of bone: comparison between a contemporary cohort and a historical cohort. Bone 170, 116721 (2023). https:\/\/doi.org\/10.1016\/j.bone.2023.116721","journal-title":"Bone"},{"issue":"2","key":"3791_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S8756-3282(01)00674-3","volume":"30","author":"AA Morales-Piga","year":"2002","unstructured":"A.A. Morales-Piga, F.J. Bachiller-Corral, V. Abraira, J. Beltr\u00e1n, A. Rapado, Is clinical expressiveness of Paget\u2019s disease of bone decreasing? Bone 30(2), 399\u2013403 (2002). https:\/\/doi.org\/10.1016\/S8756-3282(01)00674-3","journal-title":"Bone"},{"issue":"6","key":"3791_CR6","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s00223-017-0312-1","volume":"101","author":"C Britton","year":"2017","unstructured":"C. Britton, S. Brown, L. Ward, S.L. Rea, T. Ratajczak, J.P. Walsh, The changing presentation of Paget\u2019s disease of bone in Australia, a high prevalence region. Calcif. Tissue Int 101(6), 564\u2013569 (2017). https:\/\/doi.org\/10.1007\/s00223-017-0312-1","journal-title":"Calcif. Tissue Int"},{"issue":"3","key":"3791_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S8756-3282(00)00333-1","volume":"27","author":"RD Tiegs","year":"2000","unstructured":"R.D. Tiegs, C.M. Lohse, P.C. Wollan, L.J. Melton, Long-term trends in the incidence of Paget\u2019s disease of bone. Bone 27(3), 423\u2013427 (2000). https:\/\/doi.org\/10.1016\/S8756-3282(00)00333-1","journal-title":"Bone"},{"issue":"4","key":"3791_CR8","doi-asserted-by":"publisher","first-page":"e3657","DOI":"10.1002\/jbmr.3657","volume":"34","author":"SH Ralston","year":"2019","unstructured":"S.H. Ralston, L. Corral-Gudino, C. Cooper, R.M. Francis, W.D. Fraser, L. Gennari, N. Gua\u00f1abens, M.K. Javaid, R. Layfield, T.W. O\u2019Neill, R.G.G. Russell, M.D. Stone, K. Simpson, D. Wilkinson, R. Wills, M.C. Zillikens, S.P. Tuck, Diagnosis and management of Paget\u2019s disease of bone in adults: a clinical guideline: diagnosis and management of Paget\u2019s disease of bone. J. Bone Min. Res 34(4), e3657 (2019). https:\/\/doi.org\/10.1002\/jbmr.3657","journal-title":"J. Bone Min. Res"},{"issue":"12","key":"3791_CR9","doi-asserted-by":"publisher","first-page":"4408","DOI":"10.1210\/jc.2014-2910","volume":"99","author":"FR Singer","year":"2014","unstructured":"F.R. Singer, H.G. Bone, D.J. Hosking, K.W. Lyles, M.H. Murad, I.R. Reid, E.S. Siris; Endocrine Society, Paget\u2019s disease of bone: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(12), 4408\u20134422 (2014). https:\/\/doi.org\/10.1210\/jc.2014-2910","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"592","key":"3791_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1259\/0007-1285-50-592-243","volume":"50","author":"JP Lavender","year":"1977","unstructured":"J.P. Lavender, I.M.A. Evans, R. Arnot, S. Bowring, F.H. Doyle, G.F. Joplin, I. MacIntyre, A comparison of radiography and radioisotope scanning in the detection of Paget\u2019s disease and in the assessment of response to human calcitonin. BJR 50(592), 243\u2013250 (1977). https:\/\/doi.org\/10.1259\/0007-1285-50-592-243","journal-title":"BJR"},{"issue":"4","key":"3791_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0002-9343(96)00227-6","volume":"101","author":"IR Reid","year":"1996","unstructured":"I.R. Reid, G.C. Nicholson, R.S. Weinstein, D.J. Hosking, T. Cundy, M.A. Kotowicz, W.A. Murphy, S. Yeap, S. Dufresne, A. Lombardi, T.A. Musliner, D.E. Thompson, A. John Yates, Biochemical and radiologic improvement in Paget\u2019s disease of bone treated with alendronate: a randomized, placebo-controlled trial. Am. J. Med. 101(4), 341\u2013348 (1996). https:\/\/doi.org\/10.1016\/S0002-9343(96)00227-6","journal-title":"Am. J. Med."},{"issue":"5","key":"3791_CR12","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0002-9343(99)00062-5","volume":"106","author":"PD Miller","year":"1999","unstructured":"P.D. Miller, J.P. Brown, E.S. Siris, M.S. Hoseyni, D.W. Axelrod, P.J. Bekker, A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget\u2019s disease of bone. Am. J. Med. 106(5), 513\u2013520 (1999). https:\/\/doi.org\/10.1016\/S0002-9343(99)00062-5","journal-title":"Am. J. Med."},{"issue":"4","key":"3791_CR13","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.bone.2003.12.011","volume":"34","author":"JP Walsh","year":"2004","unstructured":"J.P. Walsh, L.C. Ward, G.O. Stewart, R.K. Will, R.A. Criddle, R.L. Prince, B.G.A. Stuckey, S.S. Dhaliwal, C.I. Bhagat, R.W. Retallack, G.N. Kent, P.J. Drury, S. Vasikaran, D.H. Gutteridge, A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget\u2019s disease of bone. Bone 34(4), 747\u2013754 (2004). https:\/\/doi.org\/10.1016\/j.bone.2003.12.011","journal-title":"Bone"},{"issue":"9","key":"3791_CR14","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1056\/NEJMoa044241","volume":"353","author":"IR Reid","year":"2005","unstructured":"I.R. Reid, P. Miller, K. Lyles, W. Fraser, J.P. Brown, Y. Saidi, P. Mesenbrink, G. Su, J. Pak, K. Zelenakas, M. Luchi, P. Richardson, D. Hosking, Comparison of a single infusion of zoledronic acid with risedronate for Paget\u2019s disease. N. Engl. J. Med 353(9), 898\u2013908 (2005). https:\/\/doi.org\/10.1056\/NEJMoa044241","journal-title":"N. Engl. J. Med"},{"issue":"9","key":"3791_CR15","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/jbmr.438","volume":"26","author":"IR Reid","year":"2011","unstructured":"I.R. Reid, K. Lyles, G. Su, J.P. Brown, J.P. Walsh, J. del Pino-Montes, P.D. Miller, W.D. Fraser, S. Cafoncelli, C. Bucci-Rechtweg, D.J. Hosking, A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5 years. J. Bone Min. Res 26(9), 2261\u20132270 (2011). https:\/\/doi.org\/10.1002\/jbmr.438","journal-title":"J. Bone Min. Res"},{"issue":"10","key":"3791_CR16","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1359\/jbmr.070704","volume":"22","author":"D Merlotti","year":"2007","unstructured":"D. Merlotti, L. Gennari, G. Martini, F. Valleggi, V. De Paola, A. Avanzati, R. Nuti, Comparison of different intravenous bisphosphonate regimens for Paget\u2019s disease of bone. J. Bone Min. Res 22(10), 1510\u20131517 (2007). https:\/\/doi.org\/10.1359\/jbmr.070704","journal-title":"J. Bone Min. Res"},{"issue":"1","key":"3791_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1359\/jbmr.061001","volume":"22","author":"D Hosking","year":"2007","unstructured":"D. Hosking, K. Lyles, J.P. Brown, W.D. Fraser, P. Miller, M.D. Curiel, J.-P. Devogelaer, M. Hooper, G. Su, K. Zelenakas, J. Pak, T. Fashola, Y. Saidi, E.F. Eriksen, I.R. Reid, Long-term control of bone turnover in Paget\u2019s disease with zoledronic acid and risedronate. J. Bone Min. Res 22(1), 142\u2013148 (2007). https:\/\/doi.org\/10.1359\/jbmr.061001","journal-title":"J. Bone Min. Res"},{"issue":"5","key":"3791_CR18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00223-014-9904-1","volume":"95","author":"A Tan","year":"2014","unstructured":"A. Tan, S.H. Ralston, Clinical presentation of Paget\u2019s disease: evaluation of a contemporary cohort and systematic review. Calcif. Tissue Int 95(5), 385\u2013392 (2014). https:\/\/doi.org\/10.1007\/s00223-014-9904-1","journal-title":"Calcif. Tissue Int"},{"issue":"4","key":"3791_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00223-021-00848-x","volume":"109","author":"M Barale","year":"2021","unstructured":"M. Barale, S. Sigrist, F. Bioletto, F. Maiorino, E. Ghigo, R. Mazzetti, M. Procopio, Long-term efficacy of intensive zoledronate therapy and predictors of retreatment in Paget\u2019s disease of bone. Calcif. Tissue Int 109(4), 383\u2013392 (2021). https:\/\/doi.org\/10.1007\/s00223-021-00848-x","journal-title":"Calcif. Tissue Int"},{"issue":"1","key":"3791_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1359\/jbmr.090709","volume":"25","author":"AL Langston","year":"2010","unstructured":"A.L. Langston, M.K. Campbell, W.D. Fraser, G.S. MacLennan, P.L. Selby, S.H. Ralston, Randomized trial of intensive bisphosphonate treatment versus symptomatic management in Paget\u2019s disease of bone. J. Bone Min. Res 25(1), 20\u201331 (2010). https:\/\/doi.org\/10.1359\/jbmr.090709","journal-title":"J. Bone Min. Res"},{"issue":"6","key":"3791_CR21","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/jbmr.3066","volume":"32","author":"A Tan","year":"2017","unstructured":"A. Tan, K. Goodman, A. Walker, J. Hudson, G.S. MacLennan, P.L. Selby, W.D. Fraser, S.H. Ralston; for the PRISM-EZ Trial Group, Long-term randomized trial of intensive versus symptomatic management in Paget\u2019s disease of bone: the PRISM-EZ study: intensive bisphosphonate therapy in Paget\u2019s disease of bone. J. Bone Min. Res 32(6), 1165\u20131173 (2017). https:\/\/doi.org\/10.1002\/jbmr.3066","journal-title":"J. Bone Min. Res"},{"issue":"4","key":"3791_CR22","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/jbmr.3029","volume":"32","author":"T Cundy","year":"2017","unstructured":"T. Cundy, K. Maslowski, A. Grey, I.R. Reid, Durability of response to zoledronate treatment and competing mortality in Paget\u2019s disease of bone. J. Bone Min. Res 32(4), 753\u2013756 (2017). https:\/\/doi.org\/10.1002\/jbmr.3029","journal-title":"J. Bone Min. Res"},{"key":"3791_CR23","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/bonekey.2013.176","volume":"2","author":"IR Reid","year":"2013","unstructured":"I.R. Reid, J.P. Brown, N. Levitt, J.A. Rom\u00e1n Ivorra, J. Bachiller-Corral, I.L. Ross, G. Su, O. Antunez-Flores, R.P. Aftring, Re-treatment of relapsed Paget\u2019s disease of bone with zoledronic acid: results from an open-label study. Bonekey Rep. 2, 442 (2013). https:\/\/doi.org\/10.1038\/bonekey.2013.176","journal-title":"Bonekey Rep."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03791-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-03791-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03791-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T11:59:41Z","timestamp":1722427181000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-03791-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,30]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["3791"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-03791-7","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,30]]},"assertion":[{"value":"31 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}